Evidence map›Paper›PMID 40090898›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Synthesis and Properties of Cyclic Imide Extended Diazocines: Tweezer-Like, Rigid Photoswitches with Large Switching Amplitudes.

Artjom Businski, Thuy C Ta, Lara Unterriker, Niklas Gindullis, Jan-Simon von Glasenapp, Christian Näther, Rainer Herges

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Reversible phase transition in 8,19-dimethyl-2,3,8,19-tetra-aza-penta-cyclo[13.7.0.0Acta crystallographica. Section E, Crystallographic communications · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Artjom BusinskiOtto Diels Institute of Organic Chemistry, Kiel University, Kiel, Germany.
Thuy C TaOtto Diels Institute of Organic Chemistry, Kiel University, Kiel, Germany.
Lara UnterrikerOtto Diels Institute of Organic Chemistry, Kiel University, Kiel, Germany.
Niklas GindullisInstitute of Organic Chemistry, Hannover University, Hannover, Germany.
Jan-Simon von GlasenappOtto Diels Institute of Organic Chemistry, Kiel University, Kiel, Germany.
Christian NätherInstitute of Inorganic Chemistry, Kiel University, Kiel, Germany.
Rainer HergesOtto Diels Institute of Organic Chemistry, Kiel University, Kiel, Germany.ORCID https://orcid.org/0000-0002-6396-6991

Funding

Deutsche Forschungsgemeinschaft HE 1530/24-1
6 · The paper itself

Abstract

Diazocines are bridged azobenzenes with improved photophysical properties. One of the main features is the fact that, unlike the azobenzenes, the Z form is more stable than the E isomer. Another important property is the more rigid structure (tricyclic), which precisely defines the molecular movement. The disadvantage of diazocines compared to azobenzenes is the less well-developed chemistry, particularly regarding the synthesis of derivatives. In this work, we present an approach to preparing diazocine derivatives via a late-stage functionalization strategy. Two key compounds are used for this purpose: a bis-anhydride and a bis-imide of diazocine. They can be further functionalized with both nucleophiles and electrophiles leading to numerous derivatives of diazocine with a large range of functional groups. Due to the extended π systems, the associated larger molecular switching lever, and the defined direction of molecular movement, numerous potential applications in the field of photoswitchable biological systems and photoresponsive materials are conceivable, e.g. photopharmacology, polymer-based actuators, mechanophores, photoresponsive cages, helicates, MOFs, and COFs.

Indexed as

azo compounddiazocineimidelate‐stage‐derivatizationphotochemistryphotochromismphotoswitch

Identifiers

PMID40090898
PMCPMC12099182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.